Who owns ATARA BIOTHERAPEUTICS INC?
- Ticker: ATRA
- CUSIP Number: 046513206
Tip: Access positions for across all investors
Analyze quarterly positions in Atara Biotherapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Atara Biotherapeutics stock
Who bought or sold ATARA BIOTHERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| EcoR1 Capital | 1.6M | $18M | 1458% | Jun 2026 |
|
| Adage Capital Partners GP | 850k | $9.8M | 21% | Jun 2026 |
|
| Point72 Asset Management | 688k | $7.9M | 254% | Jun 2026 |
|
| Redmile Group | 442k | $5.1M | 0% | Jun 2026 |
|
| Vanguard Capital Management | 247k | $2.8M | 13% | Jun 2026 |
|
| Mackenzie Financial | 233k | $2.7M | -26% | Jun 2026 |
|
| BlackRock | 85k | $970k | 7% | Jun 2026 |
|
| Geode Capital Management | 75k | $863k | 14% | Jun 2026 |
|
| Staley Capital Advisers | 50k | $574k | 0% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 43k | $494k | 28% | Jun 2026 |
|
| Acadian Asset Management | 39k | $444k | -70% | Jun 2026 |
|
| Jane Street | 30k | $348k | -10% | Jun 2026 |
|
| State Street Corporation | 27k | $125k | 0% | Mar 2026 |
|
| Northern Trust | 17k | $191k | 34% | Jun 2026 |
|
| FMR | 16k | $186k | 0% | Jun 2026 |
|
| XTX Topco | 15k | $176k | 100% | Jun 2026 |
|
| Bridgeway Capital Management | 14k | $161k | -57% | Jun 2026 |
|
| Millennium Management | 13k | $146k | -73% | Jun 2026 |
|
| Citadel Advisors | 10k | $117k | 100% | Jun 2026 |
|
| Morgan Stanley | 9.2k | $43k | -43% | Mar 2026 |
|
| Royal Bank of Canada | 4.7k | $56k | 10% | Jun 2026 |
|
| UBS Group | 4.0k | $46k | -92% | Jun 2026 |
|
| Vanguard Global Advisers | 1.5k | $17k | 0% | Jun 2026 |
|
| SBI Securities | 1.4k | $16k | -11% | Jun 2026 |
|
| Jones Financial Companies, L.L | 803.00 | $8.4k | 14% | Jun 2026 |
|
| Caitong International Asset Management | 311.00 | $3.6k | 100% | Jun 2026 |
|
| Barclays | 304.00 | $3.5k | 100% | Jun 2026 |
|
| Wells Fargo & Company | 251.00 | $2.9k | 0% | Jun 2026 |
|
| Jpmorgan Chase & Co | 216.00 | $2.4k | 100% | Jun 2026 |
|
| Raiffeisen Bank International | 200.00 | $2.3k | 0% | Jun 2026 |
|
| Banque Transatlantique SA | 176.00 | $3.1k | 0% | Jun 2026 |
|
| Bnp Paribas Arbitrage, Snc | 46.00 | $528.001800 | -21% | Jun 2026 |
|
| KERR FINANCIAL PLANNING Corp | 24.00 | $276.000000 | 0% | Jun 2026 |
|
| Advisor Group Holdings | 10.00 | $114.000000 | 0% | Jun 2026 |
|
| Rockefeller Capital Management | 8.00 | $92.000000 | 0% | Jun 2026 |
|
| Citigroup | 1.00 | $5.000000 | 100% | Mar 2026 |
|
Who sold out of Atara Biotherapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Rhumbline Advisers | Mar 2026 | 175.00 | $826.997500 |